Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

66455 1511539639HCLSTunisiaNovember2017.pdf
Energy Boardroom

Priority Review Voucher Accompanies FDA Approval of Impavido for Leishmaniasis

25.03.2014 / Thomson Reuters Blog

FDA approval of Impavido (miltefosine) to treat a tropical parasitic infection rare in the US has also earned Knight Therapeutics, Inc, a priority review voucher – the fourth-ever granted by the FDA. Knight is a spin-off of Paladin Labs Inc, the company that filed for Impavido approval. Knight formed in February when Endo Health Solutions […]

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: